Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sanofi Consumer Healthcare IndiaBOM:544250 -0.32%21 Dividend Payout Ratio is 2.51 as of Jun. 2026, which is 365% above its 10-year median of 0.54. GuruFocus rates BOM:544250 with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 446 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks worse than 77.8% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sanofi Consumer Healthcare India's Dividend Payout Ratio for the
months ended in Jun. 2026 was 2.51.
The historical rank and industry rank for Sanofi Consumer Healthcare India's Dividend Payout Ratio or its related term are showing as below:
BOM:544250'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.54 Med: 0.54 Max: 0.65
Current: 0.65
During the past 3 years, the highest Dividend Payout Ratio of Sanofi Consumer Healthcare India was 0.65. The lowest was 0.54. And the median was 0.54.
BOM:544250's Dividend Payout Ratio is ranked worse than 77.8% of 446
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs BOM:544250: 0.65
During the past 3 years, the highest Trailing Annual Dividend Yield of Sanofi Consumer Healthcare India was 1.68%. The lowest was 1.03%. And the median was 1.18%.
Sanofi Consumer Healthcare India (BOM:544250) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sanofi Consumer Healthcare India Dividend Payout Ratio Related Terms
Sanofi Consumer Healthcare India Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India Dividend Payout Ratio Chart
BOM:544250 vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi Consumer Healthcare India Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's Dividend Payout Ratio falls into.
Sanofi Consumer Healthcare India Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India (BOM:544250) has a Dividend Payout Ratio of 2.51 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sanofi Consumer Healthcare India and its competitors. This is 365% above median its historical median of 0.54. Over the past decade, Sanofi Consumer Healthcare India's Dividend Payout Ratio has ranged from 0.54 to 0.65. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #347 out of 446 companies in the Drug Manufacturers industry, placing it in the top 77.8%.
Is Sanofi Consumer Healthcare India's Dividend Payout Ratio too high?
Sanofi Consumer Healthcare India's current Dividend Payout Ratio of 2.51 is 365% above median its 10-year median of 0.54. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 0.65. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Sanofi Consumer Healthcare India's value of 2.51 is 569.3% above this industry median. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #347 out of 446 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #347 out of 446 companies for Dividend Payout Ratio. This places Sanofi Consumer Healthcare India in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Sanofi Consumer Healthcare India's value of 2.51 is 569.3% above this benchmark. Historically, Sanofi Consumer Healthcare India's own Dividend Payout Ratio has ranged from 0.54 to 0.65 over the past decade. While the company's 10-year median is 0.54 vs. the industry median of 0.38, Sanofi Consumer Healthcare India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 446 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi Consumer Healthcare India's current Dividend Payout Ratio of 2.51 is 569.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current Dividend Payout Ratio is 2.51, which is 365% above median its own 10-year median of 0.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (BOM:544250) has a current Dividend Payout Ratio of 2.51. The current Dividend Payout Ratio is 2.51, which is 365% above median its 10-year median of 0.54 and 569.3% above the Drug Manufacturers industry median of 0.38. Sanofi Consumer Healthcare India's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (BOM:544250), the current Dividend Payout Ratio is 2.51 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
21GF Score
Get the complete analysis for BOM:544250
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544250 has been successfully added to your 
